2026-04-23T08:22:03Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/ijpsdr.000013 2017-06-09 PTZ.IJPSDR:VOL3

JAK inhibitors: a promising direction for treating Rheumatoid Arthritis Pelechas Eleftherios<p>Rheumatoid Arthritis (RA) is a chronic auto inflammatory disease that causes incapacitating changes both the musculoskeletal system and the internal organs [1]. Tumor Necrosis Factor inhibitors (TNFi) promised a new revolutionary era in RA approximately 20 years ago. Since then, different TNFi molecules appeared in that direction. Nowadays, clinicians have also added in their armamentarium the first bio similar in order to combat RA. The main question is: do they have achieved their goal regarding their efficacy, and if yes, at what extent?</p> International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications 2017-06-09 Editorial https://doi.org/10.17352/ijpsdr.000013 en Copyright © Pelechas Eleftherios et al.